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Abstract: OBJECTIVE The aim of this study was to define the influence of trauma on cardiac glu-
cose and fatty acid transport. The effects were investigated in vivo in a porcine mono- and polytrauma
model and in vitro in human cardiomyocytes, which were treated simultaneously with different inflam-
matory substances, mimicking post-traumatic inflammatory conditions. METHODS AND RESULTS
In the porcine fracture- and polytrauma model, blood glucose concentrations were measured by blood
gas analysis during an observation period of 72 h. The expression of cardiac glucose and fatty acid
transporters in the left ventricle was determined by RT-qPCR and immunofluorescence. Cardiac and
hepatic glycogen storage was examined. Furthermore, human cardiomyocytes were exposed to a defined
trauma-cocktail and the expression levels of glucose- and fatty acid transporters were determined. Early
after polytrauma, hyperglycaemia was observed. After 48 h and 72 h, pigs with fracture- and polytrauma
developed hypoglycaemia. The propofol demand significantly increased post trauma. The hepatic glyco-
gen concentration was reduced 72 h after trauma. Cardiac glucose and fatty acid transporters changed in
both trauma models in vivo as well as in vitro in human cardiomyocytes in presence of proinflammatory
mediators. CONCLUSIONS Monotrauma as well as polytrauma changed the cardiac energy transport
by altering the expression of glucose and fatty acid transporters. In vitro data suggest that human car-
diomyocytes shift to a state alike myocardial hibernation preferring glucose as primary energy source in
order to maintain cardiac function.
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Abstract  
Objective: The aim of this study was to define the influence of trauma on cardiac glucose 
and fatty acid transport. The effects were investigated in vivo in a porcine mono- and 
polytrauma model and in vitro in human cardiomyocytes, which were treated simultaneously 
with different inflammatory substances, mimicking post-traumatic inflammatory conditions.  
Methods and Results: In the porcine fracture- and polytrauma model, blood glucose 
concentrations were measured by blood gas analysis during an observation period of 72 h. 
The expression of cardiac glucose and fatty acid transporters in the left ventricle was 
determined by RT-qPCR and immunofluorescence. Cardiac and hepatic glycogen storage 
was examined. Furthermore, human cardiomyocytes were exposed to a defined trauma-
cocktail and the expression levels of glucose- and fatty acid transporters were determined. 
Early after polytrauma, hyperglycaemia was observed. After 48 h and 72 h, pigs with 
fracture- and polytrauma developed hypoglycaemia. The propofol demand significantly 
increased post trauma. The hepatic glycogen concentration was reduced 72 h after trauma. 
Cardiac glucose and fatty acid transporters changed in both trauma models in vivo as well as 
in vitro in human cardiomyocytes in presence of proinflammatory mediators.  
Conclusions: Monotrauma as well as polytrauma changed the cardiac energy transport by 
altering the expression of glucose and fatty acid transporters. In vitro data suggest that human 
cardiomyocytes shift to a state alike myocardial hibernation preferring glucose as primary 
energy source in order to maintain cardiac function.  
Keywords: polytrauma, cardiac fatty acid metabolism, cardiac glucose metabolism, 
myocardial hibernation 
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Introduction 
After polytrauma, patients often exhibit impaired cardiac function and cardiomyopathy, 
which is associated with an increased mortality rate 
22
. In critically ill patients nutrition is 
challenging because the stress-induced catabolism after injury predisposes to malnutrition. In 
this context catabolic hormones such as glucagon, catecholamines and cortisol are elevated, 
which is associated with mobilization of endogenous energy substrates (glucose, amino acids 
and free-fatty acids). Of note, the delivery of these substrates to the vital organs brain and 
heart is prioritized 
20





, and this stress response triggers hyperglycaemia, which is associated with 
increased mortality 
33
. During intensive care patients are further challenged by prolonged 
fasting periods or feeding interruption 
34
. In surgical patients malnutrition is associated with 
delayed healing, higher rates of complications, longer hospital stay and poor outcomes 
1
. 
Combining different single traumata changes the levels of metabolites including glycolysis, 
tri-carboxylic acid cycle, pentose phosphate and fatty acid pathways 
46
. Furthermore, trauma-
induced hepatic stress has been associated with stress metabolism, including insulin 
resistance, and resulting in increased hepatic glucose production but decreased glucose 
uptake of the skeletal muscle 
2
. In regard to the heart, we have previously demonstrated that 
polytrauma exhibit increased cardiac glycogen concentrations, but decreased glucose 
transporter 4 (GLUT4) expression in pigs 
23
. For proper cardiac function a very tight coupling 
between ATP production and myocardial contraction is essential, supposing a constant 
provision of metabolites necessary for ATP production 
29
. The heart is capable of utilizing all 
classes of energy substrates. Thereby, the use of long-chain free fatty acids (LCFA) and 
carbohydrates is favored 
19
. In well oxygenated hearts the primary energy source for 
cardiomyocytes is the utilization of LCFA 
38
. Another important energy source is glycogen, 
supporting cardiac metabolism during acute cardiac workload. However, the glycogen 
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turnover rate is usually very low under normal conditions 
13
. Nevertheless, due to its 
capability to change between the different metabolisms, the human heart is able to providing 
a constant ATP production, and thus a proper function 
12, 54
. During such cardiac metabolic 
reprogramming the oxidation of LCFA is mostly reduced, whereas the glucose consumption 
increased 
4
. This shift from fatty acid oxidation to glucose utilization is especially seen in 
patients with chronic heart failure as well as with ischemic cardiomyopathy 
48
. Given that the 
intramuscular storage of LCFA is limited, the heart tissue is strongly dependent on systemic 
supply of LCFA from adipose tissue 
30
. LCFA are provided either unbound as free fatty acids 
or linked to albumin 
36
. Its uptake by heart tissue is a complex process, involving multiple 
steps and many barriers 
5
. The rate-limiting factor is the cellular uptake and the passage 
across the plasma membrane 
30
 since the LCFA enters cardiomyocytes either inactively by 
diffusion or actively via different transport proteins 
9, 56
. Of those, we focused on cardiac fatty 
acid transporters, including the solute carrier 27 gene family (SLC27), the heart fatty acid 
binding protein (HFABP) and the fatty acid translocase (FAT/CD36). The CD36 facilitates 
the uptake by catalyzing the accumulation and integration of protonated LCFA into the outer 
phospholipid bilayer 
49
. HFABP promotes the uptake of LCFA into the cytoplasm of 
cardiomyocytes and is responsible for the delivery of LCFA from the sarcolemma through 
the cytoplasm to the outer membrane of mitochondria 
16, 30
. Both, CD36 and HFABP 
accelerate LCFA-dissociation from albumin 
11
. SLC27 solute carrier proteins are integral 
transmembrane proteins, promoting the transport of LCFA actively across the plasma 
membrane. The SLC27A1 and SLC27A6 are expressed ubiquitous, whereas the SLC27A6 is 
almost exclusively expressed in cardiac tissue 
3, 47
. In cardiomyocytes the glucose transporters 
GLUT1 and GLUT4 are mainly involved in glucose transport 
31
. 
Trauma is associated with whole-body inflammation, upregulating cytokines, complement 
factors and damage-associated molecular patterns (DAMPs) like extracellular histones 
18, 21, 
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39, 45
. Although it has been shown that cytokines and endogenous danger molecules may have 
negative effects on the heart, leading to cardiac suppression and cardiac dysfunction 
25, 43
, the 
exact influence and underlying mechanisms are still obscure 
15
. Furthermore, little is known 
about the impact of trauma on cardiac glucose and fatty acid transport. Trauma is able to 
induce an imbalance between glucose and LCFA utilization in cardiomyocytes, leading 
finally to impaired cardiac function. Therefore, investigations regarding cardiac glucose and 
fatty acid transport during trauma are of huge importance 
8
. The aim of this report was to 
define the effects of single- and polytrauma on the cardiac glucose and fatty acid transport in 
vivo as well as in vitro.  
Materials and Methods 
In vivo experiments 
Animals  
The animal experiments were conducted in the framework of the TREAT consortium. This 
study presents results from a large animal porcine polytrauma model and all pigs from this 
animal experiments were enclosed in the present investigations. The model has been 
previously described in detail by Horst et al. 
17
. Animal experiments adhere to the Animal 




All procedures conformed to the Society of Laboratory Animal Science (GV-SOLAS) as well 
as the National Animal Welfare Law and were approved by the responsible governmental 
authorities ("Landesamt für Natur, Umwelt und Verbraucherschutz": LANUV-NRW, 
Germany: AZ TV-No.: 84-02.04.2014.A265). This study was performed according to the 
guidelines of the Federation of European Laboratory Animal Science Association (FELASA). 
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For the investigations, n=30 12-16 weeks old male pigs with a mean of 30 ± 5 kg body 
weight (Sus scrofa dormestica, Tierzucht GmbH Heinrich, Heinsberg, Germany) were 
included in the study.  
Anaesthesia  
For premedication, pigs received an intramuscular injection with azaperone (3-4 mg/kg body 
weight. Anaesthesia was performed by intravenous application of propofol (2,6-
diisopropylphenol) and sufentanil. Anaesthesia was maintained during the study period with 
propofol (1-2 mg/kg body weight). Pain medication was ensured by sufentanil (0.05 mg/ml) 
perfusion over the whole observation period. Vital parameters were monitored on a regular 
basis by electrocardiographic (ECG), pulse oximetry and blood gas analysis. Data on vital 
signs (heart frequency, mean arterial pressure, pO2 and FiO2) were checked according to the 
time points of whole blood sampling (1.5, 3.5, 5.5, 24, 48 and 72 h after trauma). Maintaining 
of body temperature was performed by using a forced-air warming system. Pigs were bedded 
every 6 h in order to prevent positional damage and organ compromise. Lung function was 
maintained by lung-protective ventilation and changing position. Liver function was 
monitored by aspartate-aminotransferase (AST) and alanine-aminotransferase (ALT) 
measurements. Kidney function was controlled by sampling of urine and measuring systemic 
creatinine values. 
Fluids were administered by continuous crystalloid infusion (Sterofundin ISO®; 2 ml/kg 
body weight /h). The pigs were then orotracheally intubated and ventilation was conducted in 
biphasic positive airway pressure (BiPAP) mode 
17
. Detailed information about animal care 
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Nutrition  
Pigs received 16.6 ml/kg/24 h Amminopäd® 10% (Baxter, Unterschleißheim, Germany), 
except on the day of trauma.  
Monotrauma Pig (Fracture) 
Pigs underwent either monotrauma with femur fracture (n=12) or sham procedure (n=6). The 
sham procedure included solely anaesthesia without trauma. The monotrauma fracture group 
(n=12) was randomized into two therapeutic groups (n=6). One group received an external 
fixation of the femur fracture corresponding to damage control orthopaedics (DCO), the other 
group were treated with femoral nailing in accordance to early total care principles (ETC).   
Polytrauma Pig  
The applied polytrauma porcine model was previously published 
17
. In brief, pigs with 
polytrauma (n=12) underwent a combination of blunt chest trauma, penetrating liver injury 
and femur fracture, followed by pressure-controlled hemorrhage (mean arterial pressure of 40 
± 5 mm Hg, maximal withdrawal of 45% of calculated total blood volume) for 90 min. The 
polytrauma group (n=12) was randomized in two therapeutic arms (n=6); external fixation of 
the femur fracture corresponding to damage control orthopaedics (DCO) or femoral nailing 
reflecting early total care (ETC).  
Sample collection 
Full blood samples were collected prior to trauma, directly as well as 1.5, 3.5, 5.5, 24, 48 and 
72 h after trauma. After centrifugation (2000 g, 15 min, 4°C), serum was removed and stored 
at -80°C until analysis. Heart tissue from left ventricle as well as liver tissue were collected 
72 h after trauma and were either fixed with 4% formalin followed by embedding in paraffin 
or quick-frozen in liquid nitrogen followed by storage at -80°C.  
Copyright © 2019 by the Shock Society. Unauthorized reproduction of this article is prohibited.
In vitro experiments 
Human stem cell-derived cardiomyocytes (iPS) from Cellular Dynamics (Madison, WI, 
USA) were cultured in iCell Maintenance Medium for 10 days at 37°C in an atmosphere of 
7% CO2. Cells were then treated with polytrauma cocktail (PTC, Supplemental Table 1, 
Supplemental Digital Content 1, http://links.lww.com/SHK/A904), supplemented with 20 
µg/ml whole histone fraction from calf thymus (Sigma Aldrich, St. Louis, MO, USA) for 6 h 
at 37°C in an atmosphere of 7% CO2. The control group was cultured in iCell Maintenance 
Medium. The concentrations of the respective cytokines included in the PTC were adjusted to 
concentrations measured in the blood of polytrauma patients. Concentrations of extracellular 
histones were adjusted to serum levels in the pigs (13). 
RNA Isolation 
RNA from left ventricles was isolated using TRIzol™ reagent (Invitrogen, Carlsbad, CA, 
USA). Remaining DNA was digested using DNaseI Amplification Grade Kit (Invitrogen, 
Carlsbad, CA, USA). For RNA isolation from cell lysates, ISOLATE II RNA Mini Kit 
(Meridian Bioscience, Cincinnati, OH, USA) was used and remaining DNA was digested by 
DNase I (Meridian Bioscience, Cincinnati, OH, USA).  
Quantitative reverse transcribed polymerase chain reaction (RT-qPCR)  
The respective RNA samples were reverse transcribed in cDNA using SuperScript™ IV 
VILO™ MasterMix (Invitrogen, Carlsbad, CA, USA). For quantitative PCR the PowerUp™ 
SYBR™ Green Master Mix was used (Applied Biosystems, Waltham, MA, USA). All 
procedures were performed according to the manufactures instructions. For qPCR the 
QuantStudio3 system (Applied Biosystems, Waltham, MA, USA) was utilized. Following 
genes were examined from pig and from human, respectively: GLUT1, GLUT4, SLC27A1, 
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SLC27A6, FABP3 and CD36 (Supplemental Table 3, Supplemental Digital Content 2, 
http://links.lww.com/SHK/A905 and Supplemental Table 4, Supplemental Digital Content 3, 
http://links.lww.com/SHK/A906). mRNA expression of the respective genes was normalized 
to GAPDH expression. Quantitative mRNA expression was calculated by the cycle threshold 
method ΔΔCt. Results are presented as mean fold change.  
Immunofluorescence staining (IF) and PAS staining 
Paraffin sections of the respective left ventricles were deparaffinized and rehydrated. Antigen 
unmasking was performed in 10 mmol/L citrate buffer (pH 6) at 100°C and unspecific 
binding sites were blocked with 5% goat serum. Specific antigen binding was performed by 
incubation with the respective first antibody (Supplemental Table 2, Supplemental Digital 
Content 4, http://links.lww.com/SHK/A907). Specific antibody binding was detected with 
AlexaFluor®488-labeled second antibody (Jackson Immunoresearch, West Grove, PA, 
USA). Nuclei were counterstained with Hoechst and sections were mounted. Expression of 
the respective receptors was analyzed by fluorescence microscopy using an Axio ImagerM.1 
microscope and the Zeiss AxioVision software 4.9 (Zeiss, Jena, Germany) with 40x 
magnification (N.A. 0.75). Fluorescence intensities were evaluated using ImageJ software 
(National Institutes of Health, Bethesda, MD, USA) and results are presented as mean pixel 
density of each group.  
PAS staining was performed using PAS-staining-Kit (Merckmillipore, Darmstadt, Germany). 
Signal density was measured using an Axio ImagerM.1 microscope and the Zeiss AxioVision 
software 4.9 (Zeiss, Jena, Germany) with 40x magnification (N.A. 0.75). Results are 
presented as mean density of each group (arbitrary units).  
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Statistical Analysis 
A GraphPad Prism 7.0 software was used for statistical analysis (GraphPad Software, 
Incorporated, San Diego, Ca, USA). All values are expressed as means ± SEM. Data were 
analyzed by one-way ANOVA followed by Dunnett’s or Tukey’s multiple comparison test.  
p<0.05 was considered statistically significant.  
Results 
Blood glucose and propofol concentrations during polytrauma, fracture and sham procedure  
In order to determine the blood glucose concentrations during trauma, blood gas parameters 
were measured before, directly as well as 1.5, 3.5, 5.5, 24, 48 and 72 h after trauma. Pigs 
subjected to polytrauma exhibited hyperglycaemia immediately after trauma in both 
treatment groups (fig. 1 A). In polytrauma- and in fracture groups, blood glucose levels 
significantly decreased between 48 h and 72 h in the respective treatment groups compared to 
their baseline levels, developing hypoglycaemia (fig. 1 A). Blood glucose levels from pigs 
subjected to fracture increased during the first 5 h, but decreased 24 h thereafter (fig. 1 A). 
Sham treated animals likewise developed hypoglycaemia after 48 h. Propofol demand 
increased significantly in all groups after 48 h and 72 h compared to baseline levels (fig. 1 B).  
Cardiac and hepatic glycogen amount after polytrauma, fracture and sham procedure  
Tissue from heart as well as from liver was collected 72 h after polytrauma and after fracture, 
followed by DCO or ETC treatment or after sham-procedure, respectively. Additionally, liver 
tissue from non-treated healthy pigs of a historical group was collected and used as control. 
The hepatic glycogen amounts of sham-treated, fracture and polytrauma pigs decreased 
compared to healthy control pigs (fig. 2 A, B). Further, the hepatic glycogen amount of 
fracture pigs treated with ETC and of polytrauma pigs, treated with DCO decreased 
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significantly after 72 h compared to the control group (fig. 2 A, B). Cardiac glycogen storage 
decreased significantly after 72 h in the fracture group with ETC treatment, compared to the 
control group (fig. 2 C, D).  
Cardiac glucose transport in pigs after fracture  
Tissue of left ventricles was collected 72 h after fracture, ensued by DCO or ETC treatment 
or after sham procedure, respectively. GLUT1 mRNA expression significantly decreased in 
both, DCO and ETC treated pigs, whereas the GLUT1 protein levels did not differ 
considerably between the respective treated groups (fig. 3 A, B). GLUT4 mRNA expression 
significantly increased in pigs treated with ETC (fig. 3 C).  
Cardiac fatty acid transport in pigs after fracture  
The SLC27A1 mRNA expression did not differ between the respective treated groups, 
whereas the SLC27A6 mRNA expression decreased significantly in pigs treated with DCO 
(fig. 4 A, B). The HFABP mRNA expression decreased significantly in both treated groups, 
whereas on protein level no differences were visible between the respective groups (fig. 4 D, 
E). The CD36 mRNA expression and the CD36 protein expression decreased significantly in 
animals treated with DCO (fig. 4 F, G, Supplement fig.1 A, Supplemental Digital Content 5, 
http://links.lww.com/SHK/A908).   
Cardiac glucose transport in pigs after polytrauma  
Tissue homogenates and sections of left ventricles were collected 72 h after polytrauma, 
followed by DCO or ETC treatment or after sham procedure, respectively. GLUT1 mRNA 
levels decreased significantly in pigs obtained ETC treatment compared to pigs received 
sham procedure or DCO treatment (fig. 5 A). On protein level, the extracellular GLUT1 
expression did not differ significantly between the groups (fig. 5 B, Supplement fig. 1 B, 
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Supplemental Digital Content 5, http://links.lww.com/SHK/A908), whereas the intracellular 
GLUT1 protein expression increased significantly in ventricles from pigs subjected to DCO 
treatment (fig. 5 C, Supplement fig. 1 C, Supplemental Digital Content 5, 
http://links.lww.com/SHK/A908).  
Cardiac fatty acid transport in pigs after polytrauma  
SLC27A1 mRNA expression increased significantly in pigs with DCO treatment compared to 
pigs with sham procedure. SLC27A1 mRNA expression decreased significantly in ETC 
treated pigs compared to pigs with DCO treatment (fig. 6 A). SLC27A6 mRNA expression 
increased significantly in pigs that received DCO or ETC treatment, whereas the extracellular 
SLC27A6 protein expression decreased in both treated groups (fig. 6 B, C, Supplement fig. 1 
D, Supplemental Digital Content 5, http://links.lww.com/SHK/A908). HFABP mRNA 
expression and protein expression increased significantly in pigs obtained DCO treatment 
(fig. 6 D, E). CD36 mRNA expression decreased significantly in pigs with ETC treatment, 
whereas the protein expression level of CD36 did not differ significantly between the 
respective groups (fig. 6 F, G, Supplement fig. 1 E, Supplemental Digital Content 5, 
http://links.lww.com/SHK/A908).  
Cardiac glucose and fatty acid transport in human cardiomyocytes in presence of 
polytraumacocktail and extracellular histones  
Human cardiomyocytes were incubated for 6 h with PTC and additional extracellular 
histones. The control group was incubated in cell culture medium. GLUT1 mRNA expression 
increased significantly in cardiomyocytes treated with PTC and extracellular histones, 
whereas the GLUT4 mRNA expression did not differ significantly between the treated and 
the control group (fig. 7 A, B). SLC27A1 and SLC27A6 mRNA expression did not differ 
considerably between the respective groups (fig. 7 C, D). HFABP and CD36 mRNA 
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expression decreased significantly in cardiomyocytes treated with PTC and extracellular 
histones (fig. 7 E, F).  
Discussion 
In this report the effects of severe polytrauma and fracture on cardiac glucose- and fatty acid 
utilization were described in vivo and in vitro in presence of an inflammation cocktail. 
Polytrauma in pigs induced a hypermetabolic stress response, which is reflected by early 
increased blood glucose concentrations. This trauma-related metabolic stress response is 
caused by increased concentrations of circulating catecholamines and glucocorticoids, which 
is also a well-known problem in traumatized patients, and which is further associated with 
increased mortality rates as well 
10, 26
. Of note, adequate pre-medication by analgo-sedation 
with sufentanil did not reduce high baseline glucose levels in all groups. The depleted 
glycogen storage in liver by the respective trauma models might also be due to increased 
glycolysis after trauma. Furthermore, enhanced metabolic rate (20-25%) was observed after 
trauma and was associated with the severity of trauma 
42
. Peripheral insulin resistance during 
hyperglycaemia probably leads additionally to enhanced hepatic glycolysis and further 
decreased glucose uptake of the skeletal and cardiac muscle tissue 
33
. This hyperglycaemic 
state is often critical for multiply injured patients, rising their risk for mortality 
26, 33
. 
Interestingly, cardiac glycogen concentration, which has been associated with protection 
against trauma-induced cardiac damage 
40
, decreased in animals after monotrauma, but not 
after polytrauma as demonstrated before 
23
. After initial hyperglycaemia in pigs post fracture 
and ETC treatment and in pigs post polytrauma, mean systemic glucose concentration 
dropped below 100 mg/dl. GLUT1 mRNA expression decreased in both trauma models after 
72 h, indicating extensive glucose utilization during trauma. GLUT4 expression was not 
significantly altered between the respective trauma groups 
23
. But this was probably due to 
the trauma-dependent insulin resistance, since insulin predominantly stimulates the GLUT4 
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expression of the cardiomyocytes 
31
. One limitation factor for the present analysis of glucose 
consumption after trauma might be the small animal numbers, wherefore these results should 
be interpreted carefully. Therefore, more experiments are necessary to generalize the glucose 
consumption after trauma in pigs. However, the present data are consistent with the 
hypothesis of an increased glucose consumption after experimental polytrauma (13). 
An increased demand of propofol in all groups during the observation period was observed. 
Though the propofol concentration was adapted to the depth of anaesthesia of the pigs in the 
present study. This may result in a metabolic switch from oxidative phosphorylation to 
glycolysis by targeting mitochondrial complexes I, II and III. Further, increased propofol 
concentration lead to disrupted β-oxidation, reduced mitochondrial entry of LCFA and 
consequently to accumulation of free fatty acids in cells 
27
. Excess propofol concentrations 
are known to lead to enhanced levels of acylcarnitines and inhibit transport protein carnitine 
palmitoyl transferase I (CPT1) and uncouple the mitochondrial respiratory chain in humans 
53
. The disturbance of mitochondrial electron transport also causes generation of free oxygen 
reactive species (ROS), resulting in cardiomyocyte apoptosis 
32
. This phenomenon was also 
observed in humans, called propofol infusion syndrome (PRIS). PRIS is associated with 
impaired mitochondrial function and is observed in humans with propofol demands larger 
than 4 mg/kg per body weight and at exposure times longer than 48 h 
50, 53
. In rats, propofol 
concentration in tissue during intravenous application (20 mg/kg body weight) reached 200 
µM and was also correlated with impaired electron flow through the respiratory chain, with 
coenzyme Q as the main interaction site of propofol 
51
. Furthermore, propofol induces 
contractile dysfunction in the rat myocardium 
14
. The upregulation of the GLUT1 in 
cardiomyocytes during trauma might be protective, preventing propofol-induced apoptosis of 
cardiomyocytes 
37
. GLUT4 expression was probably reduced by the presence of excessive 
lipids and free fatty acids due to increased propofol infusion 
52
. Moreover, excess exposure to 
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saturated long chain fatty acids leads to a state of so-called cardiac lipotoxicity, including 
impaired cardiac glucose metabolism, impaired insulin and catecholamine signaling, cellular 
inflammation, excess reactive oxygen species (ROS) production, inhibition of autophagy and 
activation of apoptosis 
6
.  
Since glucose consumption increased in the present trauma models in pigs with fracture or 
with polytrauma, cardiac utilization of LCFA was mostly reduced. The CD36 expression was 
completely downregulated in both trauma models. This was probably caused by a trauma-
dependent insulin resistance, since the expression of the CD36 is strongly dependent on 
insulin stimulation 
7
. Decreased CD36 expression could also be due to the profopol-induced 
shift from β-oxidation to glycolysis 7. The HFABP expression decreased in pigs 72 h after 
fracture but in contrast increased in pigs 72 h after polytrauma, receiving DCO treatment. The 
increased HFABP expression in polytrauma animals indicates some post-production of the 
protein most likely compensatory to loss of HFABP early after polytrauma 
23
. SLC27A1 and 
SLC27A6 expression also increased in pigs with polytrauma but not in pigs with fracture. 
The enhanced expression of the SLC27A1, SLC27A6 as well as of HFABP in pigs with 
polytrauma might be due to the increased demand for LCFA due to the fast glucose release 
and consumption directly after trauma. Since the upregulation of SCL27A1, SLC27A6 and 
HFABP was only observed in pigs with polytrauma, we suggest that the effects were not due 
to increased circulating propofol concentration but correlate with the severity of trauma.  
Summarized, the posttraumatic environment in vivo, influenced by inflammation, DAMPs, 
intensive care nutrition and anaesthesia changed cardiac substrate utilization by adjusting 
different transporters, which are involved in cardiac fatty acid- and glucose transport. In 
mono- and polytrauma, cardiomyocytes modified their substrate utilization from LCFA to 
glucose, indicating for high energy requirement of the heart during trauma. However, after 
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polytrauma, expression of cardiac LCFA transporters increased, indicating for trauma-
dependent but propofol-independent cardiac LCFA utilization, due to increased energy 
requirements and inflammation, correlating with the severity of trauma. Moreover, the 
observed alterations in the energy metabolism of the multiple injured pigs might cause their 
disturbed and impaired cardiac function after trauma 
23, 24, 41, 55
. In order to get a closer 
understanding about the molecular mechanisms, leading to a cardiac metabolic switch after 
trauma in vivo, additional observation points before 72 h are required.  
In vitro, changes of glucose and LCFA transporters in human cardiomyocytes in presence of 
an inflammation cocktail confirmed the in vivo observed changes. As in vivo, the GLUT1 
expression increased, whereas the GLUT4 expression was not influenced by trauma, 
assuming increased glucose transport via the GLUT1 
37
.  
It is tempting to speculate that the increased expression of the GLUT1 was due to myocardial 
hibernation, which includes the downregulation of oxygen consumption and the shift to 
anaerobic glycolysis for cardiac ATP production 
35
. Due to this adaptive response, 
cardiomyocytes are able to maintain their viability in state of energy deficiency. The 
responsible enzyme for the induction of the hibernation is the cytochrome oxidase of the 
electron transport chain in mitochondria 
35
. In human cardiomyocytes, the expression of all 
transporters involved in cardiac fatty acid transport was reduced, confirming the shift to 




In conclusion, the data indicate that human cardiomyocytes skip to the condition of 
myocardial hibernation, when treated with PTC and extracellular histones, utilizing glucose 
as primary and preferred energy source in order to maintain cardiac function and contractility 
of cardiomyocytes.  
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Figure Legends  
Figure 1: Blood glucose (mg/dl) (A) and propofol (ml/h) (B) values from blood gas analysis 
(BGA) in pigs with polytrauma, fracture or sham procedure. Pigs received either polytrauma 
or fracture, followed either by damage control orthopaedics (DCO) treatment or by early total 
care (ETC) treatment. Control pigs received sham procedure. Time of measurement was 
directly after trauma (baseline) and 1.5, 3.5, 5.5, 24, 48 and 72 h after trauma. n=6 pigs in 
each group. *p<0.05 differences to baseline concentrations.  
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Figure 2: Hepatic (A, B) and cardiac (C, D) glycogen amount (pixel density) of sham-
treated, fracture- and polytrauma and control pigs. Pigs either underwent fracture or 
polytrauma, followed either by damage control orthopaedics (DCO) treatment or by early 
total care (ETC) treatment. Control animals received sham procedure. Further, liver tissue 
from non-treated healthy pigs from historical group was collected (control). Liver tissue was 
collected 72 h after trauma. n=6 pigs in each group. *p<0.05.   
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Figure 3: Cardiac glucose transport in pigs with fracture. The fold change of glucose 1 
transporter (GLUT1) (A) and glucose 4 transporter (GLUT4) (C) mRNA, as well as the pixel 
density of the extracellular GLUT1 protein expression (B) is demonstrated. Pigs received 
fracture, followed either by damage control orthopaedics (DCO) treatment or by early total 
care orthopaedics (ETC) treatment. Control group received sham-procedure. Left ventricles 
were collected 72 h after trauma. n=6 pigs in each group. *p<0.05.  
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Figure 4: Cardiac fatty acid transport in pigs with fracture. The expressions of fatty acid 
transporter 1 (SLC27A1) (A), fatty acid transporter 6 (SLC27A6) (B), heart fatty acid 
binding protein (HFABP) (D) and fatty acid translocase (CD36) (F) mRNA, as well as the 
pixel density of SLC27A6 (C), HFABP (E) and CD36 (G) protein expression is 
demonstrated. Pigs received fracture, followed either by damage control orthopaedics (DCO) 
treatment or by early total care (ETC) treatment. Control groups were sham treated. Left 
ventricles were collected 72 h after trauma. n=6 pigs in each group. *p<0.05.  
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Figure 5: Cardiac glucose transport in pigs with polytrauma. The fold change of Glucose 1 
transporter (GLUT1) (A) mRNA, as well as the pixel density of extracellular (B) and 
intracellular GLUT1 (C) protein expression is demonstrated. Pigs received polytrauma, 
followed either by damage control orthopaedics (DCO) treatment or by early total care (ETC) 
treatment. Control group was undergoing sham procedure. Left ventricles were collected 72 h 
after trauma. n=6 pigs in each group. *p<0.05.    
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Figure 6: Cardiac fatty acid transport in pigs with polytrauma. The mRNA expression of 
fatty acid transporter 1 (SLC27A1) (A), fatty acid transporter 6 (SLC27A6) (B), heart fatty 
acid binding protein (HFABP) (D) and fatty acid translocase (CD36) (G) mRNA as well as 
the pixel density of extracellular SLC27A6 (C), HFABP (E) and CD36 (G) protein 
expression is demonstrated. Pigs received polytrauma, followed either by damage control 
orthopaedics (DCO) treatment or by early total care (ETC) treatment. Control group was 
undergoing sham procedure. Left ventricles were collected 72 h after trauma. n=6 pigs in 
each group. *p<0.05.    
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Figure 7: Cardiac glucose- and fatty acid transport in human cardiomyocytes. Human 
cardiomyocytes were either sham-treated or incubated for 6 h with polytraumacocktail PTC 
(C3a 500 ng/ml; C5a 10 ng/ml; IL-1β 200 pg/ml; IL-6 500 pg/ml; IL-8 150 pg/ml; TNFα 10 
ng/ml) and 20 µg/ml extracellular whole histone fraction mix. The mRNA expression of 
glucose transporter 1 (GLUT1) (A), glucose transporter 4 (GLUT4) (B), fatty acid transporter 
1 (SLC27A1) (C), fatty acid transporter 6 (SLC27A6) (D), heart fatty acid binding protein 
(HFABP) (E) and fatty acid translocase (CD36) (F) mRNA is illustrated. n=6 in each group. 
*p<0.05.  
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